Insiders OSE Immunotherapeutics

Equities

OSE

FR0012127173

Market Closed - Euronext Paris Other stock markets 11:35:28 2024-04-26 am EDT			5-day change	1st Jan Change
5.56 ^EUR	-0.71%		+3.35%	+29.91%

Apr. 17	OSE: licensing agreement with AbbVie enters into force	CF
Apr. 17	OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OSE Immunotherapeutics SA Appoints Eric Leire as A New Independent Director and Anne-Laure Autret-Cornet as Director	23-06-22	CI
French Biotech OSE Immunotherapeutics Terminates CEO; Successor Named	22-10-10	MT
OSE Immunotherapeutics SA Appoints Nicolas Poirier as Chief Executive Officer	22-10-07	CI
OSE Immunotherapeutics Appoints Ipsen Executive As CEO	22-07-14	MT
OSE Immunotherapeutics SA Appoints Alexis Vandier as Chief Executive Officer	22-07-13	CI
OSE Immunotherapeutics SA Appoints its International Scientific Advisory Board	22-06-09	CI
OSE Immunotherapeutics SA Appoints its International Scientific Advisory Board	22-06-09	CI
OSE Immunotherapeutics SA Appoints Alexandre Lebeaut as Independent Member of the Board of Directors	22-02-18	CI
OSE Immunotherapeutics CEO Resigns, Interim Successor Named	22-01-17	MT
OSE Immunotherapeutics SA Announces CEO Change	22-01-17	CI
OSE Immunotherapeutics Adds Chief Business Officer To Bolster Drug Development	21-12-21	MT
OSE Immunotherapeutics Sa Announces Executive Changes	21-12-20	CI
OSE Immunotherapeutics SA Appoints Nicolas Poirier as Director	19-06-26	CI
OSE Immunotherapeutics SA Announces Appointment of Julien Perrier as Chief Commercial Officer	18-12-17	CI
OSE Immunotherapeutics Announces Executive Changes	18-04-12	CI
OSE Immunotherapeutics Announces Board Changes	18-01-03	CI
OSE Immunotherapeutics SA Announces Board Appointments	17-06-14	CI
OSE Immunotherapeutics SA Appoints Dr. Frédérique Corallo, as Chief Medical Officer, Immunology	16-11-28	CI
OSE Immunotherapeutics Appoints Iris Pauporté as Clinical Project Director	16-09-15	CI
OSE Pharma Announces Management Changes	16-02-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders OSE Immunotherapeutics

Equities

OSE

FR0012127173

Insiders

Filters